These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22783927)

  • 21. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes.
    Han HD; Lee A; Song CK; Hwang T; Seong H; Lee CO; Shin BC
    Int J Pharm; 2006 Apr; 313(1-2):181-8. PubMed ID: 16540270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomes modified with superhydrophilic polymer linked to a nonphospholipid anchor exhibit reduced complement activation and enhanced circulation.
    Nag OK; Yadav VR; Croft B; Hedrick A; Awasthi V
    J Pharm Sci; 2015 Jan; 104(1):114-23. PubMed ID: 25393628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.
    Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M
    J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models.
    Huang FY; Mei WL; Li YN; Tan GH; Dai HF; Guo JL; Wang H; Huang YH; Zhao HG; Zhou SL; Li L; Lin YY
    Eur J Cancer; 2012 Sep; 48(14):2260-9. PubMed ID: 22257793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
    Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
    Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration.
    Kuai R; Yuan W; Li W; Qin Y; Tang J; Yuan M; Fu L; Ran R; Zhang Z; He Q
    Mol Pharm; 2011 Dec; 8(6):2151-61. PubMed ID: 21981683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of interfacial cholesterol-anchored polyethylene glycol on sterol-rich non-phospholipid liposomes.
    Cui ZK; Edwards K; Nieto Orellana A; Bastiat G; Benoit JP; Lafleur M
    J Colloid Interface Sci; 2014 Aug; 428():111-20. PubMed ID: 24910042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
    Unezaki S; Maruyama K; Takahashi N; Koyama M; Yuda T; Suginaka A; Iwatsuru M
    Pharm Res; 1994 Aug; 11(8):1180-5. PubMed ID: 7971721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines.
    Papagiannaros A; Dimas K; Papaioannou GT; Demetzos C
    Int J Pharm; 2005 Sep; 302(1-2):29-38. PubMed ID: 16099117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
    Hong M; Zhu S; Jiang Y; Tang G; Pei Y
    J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts.
    Colbern GT; Dykes DJ; Engbers C; Musterer R; Hiller A; Pegg E; Saville R; Weng S; Luzzio M; Uster P; Amantea M; Working PK
    Clin Cancer Res; 1998 Dec; 4(12):3077-82. PubMed ID: 9865923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation of long-circulating nolatrexed dihydrochloride liposomes and its antitumor activity].
    Chen SZ; Wang SM; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):403-5. PubMed ID: 18359701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
    J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.
    Hong RL; Tseng YL
    Cancer; 2001 May; 91(9):1826-33. PubMed ID: 11335910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin.
    Lee GY; Park K; Kim SY; Byun Y
    Eur J Pharm Biopharm; 2007 Nov; 67(3):646-54. PubMed ID: 17499491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.
    Li Y; Liu R; Shi Y; Zhang Z; Zhang X
    Theranostics; 2015; 5(6):583-96. PubMed ID: 25825598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery.
    Kanamala M; Palmer BD; Jamieson SM; Wilson WR; Wu Z
    Nanomedicine (Lond); 2019 Aug; 14(15):1971-1989. PubMed ID: 31355712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.